Genome Editing in Engineered T Cells for Cancer Immunotherapy.

Bonini C, Chapuis AG, Hudecek M, Guedan S, Magnani C, Qasim W.

DOI: 10.1089/hum.2023.128
Published: 2023-09-01
Container: Hum Gene Ther
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1089/hum.2023.128,
  title = {Genome Editing in Engineered T Cells for Cancer Immunotherapy.},
  author = {Bonini C and  Chapuis AG and  Hudecek M and  Guedan S and  Magnani C and  Qasim W.},
  year = {2023},
  journal = {Hum Gene Ther},
  doi = {10.1089/hum.2023.128},
  url = {https://doi.org/10.1089/hum.2023.128}
}

RIS

TY  - JOUR
TI  - Genome Editing in Engineered T Cells for Cancer Immunotherapy.
AU  - Bonini C
AU  -  Chapuis AG
AU  -  Hudecek M
AU  -  Guedan S
AU  -  Magnani C
AU  -  Qasim W.
PY  - 2023
JO  - Hum Gene Ther
DO  - 10.1089/hum.2023.128
UR  - https://doi.org/10.1089/hum.2023.128
ER  -

APA

C, B., AG, C., M, H., S, G., C, M., & W., Q. (2023). Genome Editing in Engineered T Cells for Cancer Immunotherapy.. Hum Gene Ther. https://doi.org/10.1089/hum.2023.128

Source records

europe-pmc · retrieved 2026-09-26T09:59:22.927Z